Estrella Non Current Liabilities Other vs Net Receivables Analysis
| ESLAW Stock | 0.09 0 3.53% |
Estrella Immunopharma financial indicator trend analysis is much more than just examining Estrella Immunopharma latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Estrella Immunopharma is a good investment. Please check the relationship between Estrella Immunopharma Non Current Liabilities Other and its Net Receivables accounts. Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
Non Current Liabilities Other vs Net Receivables
Non Current Liabilities Other vs Net Receivables Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Estrella Immunopharma Non Current Liabilities Other account and Net Receivables. At this time, the significance of the direction appears to have very strong relationship.
The correlation between Estrella Immunopharma's Non Current Liabilities Other and Net Receivables is 0.88. Overlapping area represents the amount of variation of Non Current Liabilities Other that can explain the historical movement of Net Receivables in the same time period over historical financial statements of Estrella Immunopharma, assuming nothing else is changed. The correlation between historical values of Estrella Immunopharma's Non Current Liabilities Other and Net Receivables is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Current Liabilities Other of Estrella Immunopharma are associated (or correlated) with its Net Receivables. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Receivables has no effect on the direction of Non Current Liabilities Other i.e., Estrella Immunopharma's Non Current Liabilities Other and Net Receivables go up and down completely randomly.
Correlation Coefficient | 0.88 |
| Relationship Direction | Positive |
| Relationship Strength | Strong |
Non Current Liabilities Other
Net Receivables
Most indicators from Estrella Immunopharma's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Estrella Immunopharma current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. At this time, Estrella Immunopharma's Tax Provision is fairly stable compared to the past year. Selling General Administrative is likely to climb to about 3.4 M in 2024, whereas Enterprise Value Over EBITDA is likely to drop (65.28) in 2024.
Estrella Immunopharma fundamental ratios Correlations
Click cells to compare fundamentals
Estrella Immunopharma Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Estrella Stock Analysis
When running Estrella Immunopharma's price analysis, check to measure Estrella Immunopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Estrella Immunopharma is operating at the current time. Most of Estrella Immunopharma's value examination focuses on studying past and present price action to predict the probability of Estrella Immunopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Estrella Immunopharma's price. Additionally, you may evaluate how the addition of Estrella Immunopharma to your portfolios can decrease your overall portfolio volatility.